Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Advances in Cancer Research|January 30, 2019
Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironmentAksinija A Kogan, Rena G Lapidus, Maria R Baer, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiationRachel Abbotts, Michael J Topper, Christopher Biondi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid LeukemiaMaria R Baer, Aksinija A Kogan, Søren M Bentzen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemiaAksinija A Kogan, Michael J Topper, Anna J Dellomo, et al.Proceedings of the National Academy of Sciences of the United States of America|July 12, 2020
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiencyLena J McLaughlin, Lora Stojanovic, Aksinija A Kogan, et al.Pageof 1